2025-03-012026-02-282026-02-28false07184949THE FOREST PODIATRY AND PHYSIOTHERAPY CLINIC LIMITED2026-06-17falseiso4217:GBPxbrli:pure071849492025-02-28071849492026-02-28071849492025-03-012026-02-28071849492024-02-29071849492025-02-28071849492024-03-012025-02-2807184949bus:SmallEntities2025-03-012026-02-2807184949bus:AuditExempt-NoAccountantsReport2025-03-012026-02-2807184949bus:FullAccounts2025-03-012026-02-2807184949bus:PrivateLimitedCompanyLtd2025-03-012026-02-2807184949core:WithinOneYear2026-02-2807184949core:AfterOneYear2026-02-2807184949core:WithinOneYear2025-02-2807184949core:AfterOneYear2025-02-2807184949core:ShareCapital2026-02-2807184949core:SharePremium2026-02-2807184949core:RevaluationReserve2026-02-2807184949core:OtherReservesSubtotal2026-02-2807184949core:RetainedEarningsAccumulatedLosses2026-02-2807184949core:ShareCapital2025-02-2807184949core:SharePremium2025-02-2807184949core:RevaluationReserve2025-02-2807184949core:OtherReservesSubtotal2025-02-2807184949core:RetainedEarningsAccumulatedLosses2025-02-2807184949core:LandBuildings2026-02-2807184949core:PlantMachinery2026-02-2807184949core:Vehicles2026-02-2807184949core:FurnitureFittings2026-02-2807184949core:OfficeEquipment2026-02-2807184949core:NetGoodwill2026-02-2807184949core:IntangibleAssetsOtherThanGoodwill2026-02-2807184949core:ListedExchangeTraded2026-02-2807184949core:UnlistedNon-exchangeTraded2026-02-2807184949core:LandBuildings2025-02-2807184949core:PlantMachinery2025-02-2807184949core:Vehicles2025-02-2807184949core:FurnitureFittings2025-02-2807184949core:OfficeEquipment2025-02-2807184949core:NetGoodwill2025-02-2807184949core:IntangibleAssetsOtherThanGoodwill2025-02-2807184949core:ListedExchangeTraded2025-02-2807184949core:UnlistedNon-exchangeTraded2025-02-2807184949core:LandBuildings2025-03-012026-02-2807184949core:PlantMachinery2025-03-012026-02-2807184949core:Vehicles2025-03-012026-02-2807184949core:FurnitureFittings2025-03-012026-02-2807184949core:OfficeEquipment2025-03-012026-02-2807184949core:NetGoodwill2025-03-012026-02-2807184949core:IntangibleAssetsOtherThanGoodwill2025-03-012026-02-2807184949core:ListedExchangeTraded2025-03-012026-02-2807184949core:UnlistedNon-exchangeTraded2025-03-012026-02-2807184949core:MoreThanFiveYears2025-03-012026-02-2807184949core:Non-currentFinancialInstruments2026-02-2807184949core:Non-currentFinancialInstruments2025-02-2807184949dpl:CostSales2025-03-012026-02-2807184949dpl:DistributionCosts2025-03-012026-02-2807184949core:LandBuildings2025-03-012026-02-2807184949core:PlantMachinery2025-03-012026-02-2807184949core:Vehicles2025-03-012026-02-2807184949core:FurnitureFittings2025-03-012026-02-2807184949core:OfficeEquipment2025-03-012026-02-2807184949dpl:AdministrativeExpenses2025-03-012026-02-2807184949core:NetGoodwill2025-03-012026-02-2807184949core:IntangibleAssetsOtherThanGoodwill2025-03-012026-02-2807184949dpl:GroupUndertakings2025-03-012026-02-2807184949dpl:ParticipatingInterests2025-03-012026-02-2807184949dpl:GroupUndertakingscore:ListedExchangeTraded2025-03-012026-02-2807184949core:ListedExchangeTraded2025-03-012026-02-2807184949dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-03-012026-02-2807184949core:UnlistedNon-exchangeTraded2025-03-012026-02-2807184949dpl:CostSales2024-03-012025-02-2807184949dpl:DistributionCosts2024-03-012025-02-2807184949core:LandBuildings2024-03-012025-02-2807184949core:PlantMachinery2024-03-012025-02-2807184949core:Vehicles2024-03-012025-02-2807184949core:FurnitureFittings2024-03-012025-02-2807184949core:OfficeEquipment2024-03-012025-02-2807184949dpl:AdministrativeExpenses2024-03-012025-02-2807184949core:NetGoodwill2024-03-012025-02-2807184949core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2807184949dpl:GroupUndertakings2024-03-012025-02-2807184949dpl:ParticipatingInterests2024-03-012025-02-2807184949dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2807184949core:ListedExchangeTraded2024-03-012025-02-2807184949dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2807184949core:UnlistedNon-exchangeTraded2024-03-012025-02-2807184949core:NetGoodwill2026-02-2807184949core:IntangibleAssetsOtherThanGoodwill2026-02-2807184949core:LandBuildings2026-02-2807184949core:PlantMachinery2026-02-2807184949core:Vehicles2026-02-2807184949core:FurnitureFittings2026-02-2807184949core:OfficeEquipment2026-02-2807184949core:AfterOneYear2026-02-2807184949core:WithinOneYear2026-02-2807184949core:ListedExchangeTraded2026-02-2807184949core:UnlistedNon-exchangeTraded2026-02-2807184949core:ShareCapital2026-02-2807184949core:SharePremium2026-02-2807184949core:RevaluationReserve2026-02-2807184949core:OtherReservesSubtotal2026-02-2807184949core:RetainedEarningsAccumulatedLosses2026-02-2807184949core:NetGoodwill2025-02-2807184949core:IntangibleAssetsOtherThanGoodwill2025-02-2807184949core:LandBuildings2025-02-2807184949core:PlantMachinery2025-02-2807184949core:Vehicles2025-02-2807184949core:FurnitureFittings2025-02-2807184949core:OfficeEquipment2025-02-2807184949core:AfterOneYear2025-02-2807184949core:WithinOneYear2025-02-2807184949core:ListedExchangeTraded2025-02-2807184949core:UnlistedNon-exchangeTraded2025-02-2807184949core:ShareCapital2025-02-2807184949core:SharePremium2025-02-2807184949core:RevaluationReserve2025-02-2807184949core:OtherReservesSubtotal2025-02-2807184949core:RetainedEarningsAccumulatedLosses2025-02-2807184949core:NetGoodwill2024-02-2907184949core:IntangibleAssetsOtherThanGoodwill2024-02-2907184949core:LandBuildings2024-02-2907184949core:PlantMachinery2024-02-2907184949core:Vehicles2024-02-2907184949core:FurnitureFittings2024-02-2907184949core:OfficeEquipment2024-02-2907184949core:AfterOneYear2024-02-2907184949core:WithinOneYear2024-02-2907184949core:ListedExchangeTraded2024-02-2907184949core:UnlistedNon-exchangeTraded2024-02-2907184949core:ShareCapital2024-02-2907184949core:SharePremium2024-02-2907184949core:RevaluationReserve2024-02-2907184949core:OtherReservesSubtotal2024-02-2907184949core:RetainedEarningsAccumulatedLosses2024-02-2907184949core:AfterOneYear2025-03-012026-02-2807184949core:WithinOneYear2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:CostValuation2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-012026-02-2807184949core:Non-currentFinancialInstrumentscore:CostValuation2026-02-2807184949core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-02-2807184949core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2807184949core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2807184949core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2807184949bus:Director12025-03-012026-02-2807184949bus:Director22025-03-012026-02-2807184949core:FurnitureFittingsToolsEquipment2025-02-2807184949core:FurnitureFittingsToolsEquipment2025-03-012026-02-2807184949core:FurnitureFittingsToolsEquipment2026-02-28

THE FOREST PODIATRY AND PHYSIOTHERAPY CLINIC LIMITED

Registered Number
07184949
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2026

THE FOREST PODIATRY AND PHYSIOTHERAPY CLINIC LIMITED
Company Information
for the year from 1 March 2025 to 28 February 2026

Directors

C J Gillingham
J C Gillingham

Registered Address

1 The Parade
Southampton Road
Cadnam
SO40 2NG

Registered Number

07184949 (England and Wales)
THE FOREST PODIATRY AND PHYSIOTHERAPY CLINIC LIMITED
Statement of Financial Position
28 February 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Intangible assets415,24618,979
Tangible assets510,70013,422
25,94632,401
Current assets
Stocks610,00011,507
Debtors7138,584134,959
Cash at bank and on hand5,236841
153,820147,307
Creditors amounts falling due within one year8(45,414)(64,727)
Net current assets (liabilities)108,40682,580
Total assets less current liabilities134,352114,981
Provisions for liabilities10(6,486)(8,100)
Net assets127,866106,881
Capital and reserves
Called up share capital100100
Profit and loss account127,766106,781
Shareholders' funds127,866106,881
The financial statements were approved and authorised for issue by the Board of Directors on 17 June 2026, and are signed on its behalf by:
C J Gillingham
Director
Registered Company No. 07184949
THE FOREST PODIATRY AND PHYSIOTHERAPY CLINIC LIMITED
Notes to the Financial Statements
for the year ended 28 February 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be twenty years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings10
Plant and machinery5
Fixtures and fittings5
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20262025
Average number of employees during the year44
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised.
4.Intangible assets

Other

Total

££
Cost or valuation
At 01 March 2574,66574,665
At 28 February 2674,66574,665
Amortisation and impairment
At 01 March 2555,68655,686
Charge for year3,7333,733
At 28 February 2659,41959,419
Net book value
At 28 February 2615,24615,246
At 28 February 2518,97918,979
5.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 March 2518,51867,0222,826-88,366
Additions6601,399-2,7944,853
At 28 February 2619,17868,4212,8262,79493,219
Depreciation and impairment
At 01 March 2515,84458,912188-74,944
Charge for year3216,4565652337,575
At 28 February 2616,16565,36875323382,519
Net book value
At 28 February 263,0133,0532,0732,56110,700
At 28 February 252,6748,1102,638-13,422
6.Stocks

2026

2025

££
Other stocks10,00011,507
Total10,00011,507
7.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables290-
Amounts owed by group undertakings136,436129,445
Other debtors1,0614,679
Prepayments and accrued income797835
Total138,584134,959
8.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables2,77317,197
Bank borrowings and overdrafts18,69323,214
Taxation and social security9,2388,683
Other creditors2,5641,819
Accrued liabilities and deferred income12,14613,814
Total45,41464,727
9.Creditors: amounts due after one year
10.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)6,4868,100
Total6,4868,100
11.Operating lease commitments
At 28th February 2026 (Company year end), the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £24,000 due in less than one year and £72,000 due in more than one year. (2025 – £24,000 less than one year and £96,000 due in more than one year.)
12.Parent-subsidiary relationships
The company is a wholly owned subsidiary of New Milton Foot Clinic Limited whose registered office and principal place of trading is at Parkland Place 39-41 Old Milton Road New Milton Hampshire BH25 6DJ The Company has opted not to produce group accounts.